Research Article

Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation

Table 2

Fatty liver disease diagnosis made intraoperatively by graft wedge biopsy, imaging on preoperative evaluation of donors, and by follow-up selective liver biopsy and imaging study on the recipients after living donor liver transplantation.

Fatty liver diseaseDonors, (%)Recipients, (%)
Wedge bxImagingNativeF-U bxImaging

<5%10 (33.3)8 (26.7)0 (0)8 (26.7)6 (20.0)
5–10%2 (6.7)3 (10)1 (3.3)3 (10)5 (16.7)
>10%2 (6.7)1 (3.3)0 (0)1 (3.3)1 (3.3)
Total14 (46.7)12 (40)1 (3.3)12 (40)12 (40.0)

Bx + Imaging18 (60)1 (3.3)19 (63.3)

; , Fisher’s exact test (two-sided); Bx, liver biopsy; F-U, follow-up; image Dx, imaging diagnostic methods including ultrasonography, computed tomography, and magnetic resonance imaging.